Last checked at 
LONDON, Jan 27 (Reuters) - A suspicious package at an
AstraZeneca COVID-19 vaccine plant has been made safe
and production schedules of the shots have not been affected,
the company Wockhardt UK said on Wednesday.
"We can confirm that the investigation on the suspicious
package received today has been concluded. Given that staff
safety is our main priority manufacturing was temporarily paused
whilst this took place safely. We can now confirm that the
package was made safe and staff are now being allowed back into
the facility," Wockhardt UK said in a statement.
"This temporary suspension of manufacturing has in no way
affected our production schedule and we are grateful to the
authorities and experts for their swift response and resolution
of the incident."
(Reporting by Alistair Smout and Michael Holden; editing by
James Davey)
